A detailed history of Vanguard Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,421,334 shares of BIO stock, worth $661 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,421,334
Previous 2,389,889 1.32%
Holding current value
$661 Million
Previous $772 Million 8.53%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$304.11 - $351.99 $9.56 Million - $11.1 Million
31,445 Added 1.32%
2,421,334 $837 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $12.4 Million - $16.8 Million
46,119 Added 1.97%
2,389,889 $772 Million
Q3 2023

Nov 14, 2023

SELL
$350.25 - $422.63 $18 Million - $21.7 Million
-51,443 Reduced 2.15%
2,343,770 $840 Million
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $759,602 - $1.03 Million
-2,113 Reduced 0.09%
2,395,213 $908 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $2.47 Million - $2.96 Million
5,890 Added 0.25%
2,397,326 $1.15 Billion
Q4 2022

Feb 10, 2023

BUY
$351.71 - $456.01 $14 Million - $18.2 Million
39,908 Added 1.7%
2,391,436 $1.01 Billion
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $1 Million - $1.37 Million
2,428 Added 0.1%
2,351,528 $981 Million
Q2 2022

Aug 12, 2022

BUY
$463.67 - $597.16 $14.4 Million - $18.6 Million
31,159 Added 1.34%
2,349,100 $1.16 Billion
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $16 Million - $22.4 Million
30,476 Added 1.33%
2,317,941 $1.31 Billion
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $12.9 Million - $14.5 Million
18,200 Added 0.8%
2,287,465 $1.73 Billion
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $8.18 Million - $10.3 Million
-12,433 Reduced 0.54%
2,269,265 $1.69 Billion
Q2 2021

Aug 13, 2021

BUY
$576.64 - $649.04 $1.32 Billion - $1.48 Billion
2,281,698 New
2,281,698 $1.47 Billion

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.73B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.